Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory
- PMID: 25059478
- PMCID: PMC5376055
- DOI: 10.1038/srep05824
Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory
Abstract
Containment level 4 (CL4) laboratories studying biosafety level 4 viruses are under strict regulations to conduct nonhuman primate (NHP) studies in compliance of both animal welfare and biosafety requirements. NHPs housed in open-barred cages raise concerns about cross-contamination between animals, and accidental exposure of personnel to infectious materials. To address these concerns, two NHP experiments were performed. One examined the simultaneous infection of 6 groups of NHPs with 6 different viruses (Machupo, Junin, Rift Valley Fever, Crimean-Congo Hemorrhagic Fever, Nipah and Hendra viruses). Washing personnel between handling each NHP group, floor to ceiling biobubble with HEPA filter, and plexiglass between cages were employed for partial primary containment. The second experiment employed no primary containment around open barred cages with Ebola virus infected NHPs 0.3 meters from naïve NHPs. Viral antigen-specific ELISAs, qRT-PCR and TCID50 infectious assays were utilized to determine antibody levels and viral loads. No transmission of virus to neighbouring NHPs was observed suggesting limited containment protocols are sufficient for multi-viral CL4 experiments within one room. The results support the concept that Ebola virus infection is self-contained in NHPs infected intramuscularly, at least in the present experimental conditions, and is not transmitted to naïve NHPs via an airborne route.
Conflict of interest statement
The authors declare no competing financial interests.
Figures


References
-
- Madani T. A. et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin. Infect. Dis. 37, 1084–1092 (2003). - PubMed
-
- Laughlin L. W., Meegan J. M., Strausbaugh L. J., Morens D. M. & Watten R. H. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans. R. Soc. Trop. Med. Hyg. 73, 630–633 (1979). - PubMed
-
- McIntosh B. M., Russell D., dos Santos I. & Gear J. H. Rift Valley fever in humans in South Africa. S. Afr. Med. J. 58, 803–806 (1980). - PubMed
-
- Bente D. A. et al. Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 100, 159–189 (2013). - PubMed
-
- Mertens M., Schmidt K., Ozkul A. & Groschup M. H. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Res. 98, 248–260 (2013). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical